Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-14

Clinical Trial Update: The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update on a wearable cueing device intended to reduce freezing of gait in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Queensland | Conditions: Gait Disorders, Neurologic | Phase 1 | Status: COMPLETED